Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects

KA Kim, PW Park, OJ Lee, SH Choi… - Clinical …, 2006 - Wiley Online Library
Background and Objective 1, 4‐Dihydropyridine calcium channel blockers, including
amlodipine, are mainly metabolized by cytochrome P450 (CYP) 3A. We investigated the …
被引用次数：93 相关文章

Effect of CYP3A5* 3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects

KA Kim, PW Park, OJ Lee, SH Choi… - Clinical …, 2006 - pubmed.ncbi.nlm.nih.gov
Background and objective 1, 4-Dihydropyridine calcium channel blockers, including
amlodipine, are mainly metabolized by cytochrome P450 (CYP) 3A. We investigated the …

Effect of CYP3A5* 3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects.

KA Kim, PW Park, OJ Lee, SH Choi, BH Min… - Clinical …, 2006 - europepmc.org
Methods Forty healthy male participants were enrolled and genotyped for the CYP3A5* 3
gene. Each subject ingested a 5-mg dose of amlodipine, and plasma amlodipine …

[引用][C] Effect of CYP3A5^* 3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects

KIM KA - Clin Pharmacol Ther, 2006 - cir.nii.ac.jp
Effect of CYP3A5^*3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine
in healthy Korean subjects | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Effect of CYP3A5* 3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects

KA Kim, PW Park, OJ Lee, SH Choi, BH Min… - Clinical Pharmacology & …, 2006 - infona.pl
1, 4-Dihydropyridine calcium channel blockers, including amlodipine, are mainly
metabolized by cytochrome P450 (CYP) 3A. We investigated the effect of CYP3A5* 3 …

[引用][C] Effect of CYP3A5* 3 genotype on the pharmacoldnetics and pharmacodynamics of amlodipine in healthy Korean subjects

KA KIM, PW PARK, OJ LEE, SH CHOI… - Clinical …, 2006 - pascal-francis.inist.fr
Effect of CYP3A5*3 genotype on the pharmacoldnetics and pharmacodynamics of
amlodipine in healthy Korean subjects CNRS Inist Pascal-Francis CNRS Pascal and …

Effect of CYP3A5* 3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects

KA Kim, PW Park, OJ Lee, SH Choi… - Clinical …, 2006 - pure.korea.ac.kr
Abstract Background and Objective: 1, 4-Dihydropyridine calcium channel blockers,
including amlodipine, are mainly metabolized by cytochrome P450 (CYP) 3A. We …

[引用][C] Effect of CYP3A53 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects

K KIM, P PARK, O LEE, S CHOI, B MIN… - Clinical Pharmacology …, 2006 - cir.nii.ac.jp